Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96400826 | 9640082 | 6 | F | 20150721 | 20160629 | 20131023 | 20160705 | EXP | PHHY2013CA093722 | NOVARTIS | 68.47 | YR | M | Y | 0.00000 | 20160705 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96400826 | 9640082 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, ONCE A MONTH (QMO) | 21008 | 30 | MG | /month | |||||||
96400826 | 9640082 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY FOUR WEEKS | 21008 | 30 | MG | /month | |||||||
96400826 | 9640082 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, Q2MO (30 MG EVERY 08 WEEKS) | 21008 | 30 | MG | ||||||||
96400826 | 9640082 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 50 UG, ONCE/SINGLE (TEST DOSE) | 0 | 50 | UG | 1X |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
96400826 | 9640082 | 1 | Neuroendocrine tumour |
96400826 | 9640082 | 4 | Neuroendocrine tumour |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
96400826 | 9640082 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
96400826 | 9640082 | Blood pressure diastolic decreased | |
96400826 | 9640082 | Diarrhoea | |
96400826 | 9640082 | Dyspnoea | |
96400826 | 9640082 | Hot flush | |
96400826 | 9640082 | Inappropriate schedule of drug administration | |
96400826 | 9640082 | Lung neoplasm | |
96400826 | 9640082 | Pain | |
96400826 | 9640082 | Peripheral swelling | |
96400826 | 9640082 | Vital functions abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
96400826 | 9640082 | 1 | 20130529 | 20130826 | 0 | |
96400826 | 9640082 | 4 | 20130503 | 20130503 | 0 |